Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + UDCA in PBC with Inadequate Response to UDCA
NCT05751967Phase 3Recruiting
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Feb 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by Xijing Hospital of Digestive Diseases. Started Feb 2023; status: recruiting.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT05751967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05751967.